MILLER VALUE PARTNERS, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 210 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.

Quarter-by-quarter ownership
MILLER VALUE PARTNERS, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$355,000
+14.5%
20,0000.0%0.01%
+8.3%
Q3 2019$310,000
-9.9%
20,0000.0%0.01%
-7.7%
Q2 2019$344,000
+6.8%
20,0000.0%0.01%0.0%
Q1 2019$322,000
+9.9%
20,0000.0%0.01%0.0%
Q4 2018$293,000
-90.5%
20,000
-88.2%
0.01%
-87.0%
Q3 2018$3,089,000
+7.7%
170,0000.0%0.10%
-6.5%
Q2 2018$2,868,000
-13.9%
170,0000.0%0.11%
-23.0%
Q1 2018$3,330,000
-3.3%
170,0000.0%0.14%
-5.4%
Q4 2017$3,444,000
+16.6%
170,0000.0%0.15%
+15.7%
Q3 2017$2,953,000
-75.7%
170,000
-82.1%
0.13%
-74.3%
Q2 2017$12,176,000949,8000.49%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Third Security, LLC 7,048,282$126,799,00027.23%
First Light Asset Management, LLC 1,630,591$29,334,0005.01%
SNYDER CAPITAL MANAGEMENT L P 3,393,057$61,041,0003.48%
Bellevue Group AG 7,663,956$137,874,0002.67%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 307,633$5,531,0002.52%
Lombard Odier Asset Management (Switzerland) SA 900,000$16,191,0002.17%
Elk Creek Partners, LLC 654,362$11,772,0002.02%
DOHENY ASSET MANAGEMENT /CA 127,110$2,254,0001.79%
Granite Investment Partners, LLC 1,277,438$22,981,0001.49%
Amia Capital LLP 69,409$1,249,0001.11%
View complete list of HALOZYME THERAPEUTICS INC shareholders